|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.980 USD | +0.40% |
|
-1.97% | -68.46% |
| 12-03 | Orion Lifts FY25 Outlook on Expectation of Milestone Payment for Prostate Cancer Drug | MT |
| 11-19 | Orion S.A. Gains Commercial Traction with Conductive Additives Vital for Grid Modernization | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Specialty Chemicals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 280M | - | ||||
| 73.55B | |||||
| 38.37B | |||||
| 31.93B | |||||
| 25.2B | |||||
| 17.5B |
- Stock Market
- Equities
- OEC Stock
- Charts Orion S.A.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition